Today is National Cancer Survivors Day — a day to celebrate those who have beat the odds and survived different types of cancer! As leading partners in cancer research, the ARG has successfully managed many oncology clinical research projects and clinical trials, taking each one from start to finish. We’ve proudly played a role in supporting better outcomes for cancer patients, and we’ll continue to do so. #NationalCancerSurvivorsDay #ARG20Years
Atlantic Research Group’s Post
More Relevant Posts
-
At AngioDynamics we know Interventional Oncology is an important and evolving component of comprehensive cancer care. The innovations in I.O. offer a range of benefits from diagnosis to treatment and can help expand treatment options/improve the quality of life for many patients diagnosed with cancer. Check out the latest publication from Dr. Govindarajan Narayanan, the Chief of Interventional Oncology at the Miami Cancer Institute, at the link in the comments! #interventionaloncology #MedTech #Innovation #cancercare
To view or add a comment, sign in
-
-
On World Cancer Research Day, we continue to fulfill our mission to create medications that treat blood and solid tumor cancers for all who need them. We are committed to developing what we intend to be first-in-class and best-in-class molecules with one of the largest global cancer research teams. #WorldCancerResearchDay
To view or add a comment, sign in
-
-
Discover the basics and the latest in cancer immunotherapy from top experts, including CRI Scientific Advisory Council Associate Director and Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, Dr. Jedd Wolchok, during the Cancer Research Institute’s virtual Patient Immunotherapy Summit. Watch the program on demand, at no cost, today: https://bit.ly/3Nhmefn #Immunotherapy #CancerResearch #CRISummit #PatientSummit
To view or add a comment, sign in
-
-
𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? According to The National Institutes of Health, liver cancer is the sixth most common cancer and the third leading cause of cancer death. Techsomed is dedicated to making an enhanced clinical impact in liver tumor ablation through our innovative, #AI-powered Image-Guided #Ablation Therapy (IGAT) platform. Join us in raising awareness for liver cancer this October! #LiverCancerAwarnessMonth, #LiverCancer, #HepatocellularCarcinoma #OctoberIs4Livers
To view or add a comment, sign in
-
-
We are thrilled to announce that today at 10:35 PM CEST, Dr. Denis Lacombe, our CEO, will participate in the 3rd Optimal Cancer Care Alliance Virtual Meeting. He will discuss "The EMA Cancer Medicines Forum: a way forward for treatment optimisation." For more information on Optimal Cancer Care: https://lnkd.in/ehyHZPey #CancerResearch #OptimalCancerCare #ClinicalTrials #Oncology #CancerMedicinesForum #TreatmentOptimisation #PragmaticTrials University of Chicago
To view or add a comment, sign in
-
-
During the ASCO 2024 Educational Session, we will discuss the plethora of novel agents for Head and Neck Cancer - Cesar Perez M.D. Florida Cancer Specialists & Research Institute #ASCO2024 #EducationalSession #Cancer #CancerSpecialists #Research #SquamousCellCarcinoma #OncoDaily #Oncology #Immunotherapy
To view or add a comment, sign in
-
Did you know? Over 4 million patients are eligible worldwide for immunotherapy each year. Show your support early for #WorldCancerDay, and join the Cancer Research Institute in accelerating lifesaving cancer immunotherapy research. Give today to fuel the future of cancer research: https://bit.ly/48Pp3wV #CancerResearch #Immunotherapy #FundCancerResearch
To view or add a comment, sign in
-
-
To make the biggest impact with our lung cancer research, we concentrate our efforts on five areas of focus. These are the foundation of what we do, how we approach investigator-initiated clinical trials, and how we strive to make lung cancer a survivable disease. Our studies often lead to publications in the world’s most prestigious peer-reviewed oncology journals. Follow us to learn more! #lungcancer #cancerresearch #lungcancerawareness
ALCMI's 5 Pillars to Lung Cancer Research
To view or add a comment, sign in
-
𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? According to The National Institutes of Health, liver cancer is the sixth most common cancer and the third leading cause of cancer death. Techsomed is dedicated to making an enhanced clinical impact in liver tumor ablation through our innovative, #AI-powered Image-Guided #Ablation Therapy (IGAT) platform. Join me in raising awareness for liver cancer this October! #LiverCancerAwarnessMonth, #LiverCancer, #HepatocellularCarcinoma #OctoberIs4Livers
To view or add a comment, sign in
-